Urinary drug metabolite testing in chronic heart failure patients indicates high levels of adherence with life‐prolonging therapies

AIMS: Despite medical therapy for heart failure (HF) having proven benefits of improving quality of life and survival, many patients remain under‐treated. This may be due to a combination of under‐prescription by medical professionals and poor adherence from patients. In HF, as with many other chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, Mark, Cole, Graham D., Pabari, Punam, Hadjiphilippou, Savvas, Tayal, Upasana, Mayet, Jamil, Chapman, Neil, Plymen, Carla M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120374/
https://www.ncbi.nlm.nih.gov/pubmed/33709563
http://dx.doi.org/10.1002/ehf2.13284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120374/
https://www.ncbi.nlm.nih.gov/pubmed/33709563
http://dx.doi.org/10.1002/ehf2.13284

Ejemplares similares